Published on in Vol 7, No 3 (2018): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/8655, first published .
Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Yasuhiro Hijikata 1, MD, PhD;  Masahisa Katsuno 1*, MD, PhD;  Keisuke Suzuki 1, 2, MD, PhD;  Atsushi Hashizume 1, MD, PhD;  Amane Araki 1, MD, PhD;  Shinichiro Yamada 1, MD, PhD;  Tomonori Inagaki 1, MD;  Daisuke Ito 1, MD;  Akihiro Hirakawa 3, PhD;  Fumie Kinoshita 3, MSc;  Masahiko Gosho 4, PhD;  Gen Sobue 1, 5*, MD, PhD

1 Department of Neurology, Nagoya University Graduate School of Medicine , Nagoya , JP

2 Innovation Center for Clinical Research, National Center for Geriatnics and Gerontology , Obu , JP

3 Biostatistics Section, Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of Medicine, Nagoya , JP

4 Department of Clinical Trial and Clinical Epidemiology, Faculty of Medicine, University of Tsukuba, Tsukuba , JP

5 Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine , Nagoya , JP

*these authors contributed equally